Twin Tree Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,258
Closed -$6.16M 1332
2018
Q3
$6.16M Sell
3,258
-424
-12% -$876K 0.04% 346
2018
Q2
$7.49M Buy
3,682
+470
+15% +$1.07M 0.05% 328
2018
Q1
$7.1M Sell
3,212
-308
-9% -$783K 0.06% 275
2017
Q4
$8.12M Buy
+3,520
New +$7.15M 0.06% 285

Other funds holding BLUE

Twin Tree Management's BLUE Position: Q3 2019 in Review

Twin Tree Management sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 744 shares — an estimated $1.23M sold.

Twin Tree Management first reported a position in BLUE in Q4 2017 and held it in 7 quarters. The position peaked at $1.74M in Q2 2018. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Twin Tree Management reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Twin Tree Management sold 744 bluebird bio shares in Q3 2019, an estimated $1.23M.
  • Twin Tree Management first reported a position in bluebird bio in Q4 2017 and held it in 7 quarters.
  • Twin Tree Management's bluebird bio position peaked at $1.74M in Q2 2018.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Twin Tree Management's 13F filing for Q3 2019, filed 12 Nov 2019.